Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDLX NYSE:EB NASDAQ:EVER NASDAQ:HCAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDLXCardlytics$1.88-7.8%$1.88$1.22▼$7.78$107.11M1.261.90 million shs889,076 shsEBEventbrite$2.29-6.1%$2.51$1.80▼$4.49$230.90M2.09797,331 shs666,293 shsEVEREverQuote$24.10-2.0%$24.53$16.63▼$30.03$878.45M0.37353,140 shs398,488 shsHCATHealth Catalyst$3.52-3.6%$3.86$3.48▼$9.24$254.04M1.46412,937 shs718,722 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDLXCardlytics-7.84%-23.27%+4.44%+2.17%-77.32%EBEventbrite-5.95%-6.72%-15.19%+7.01%-53.17%EVEREverQuote-1.99%-6.26%-0.37%-9.77%-7.63%HCATHealth Catalyst-3.56%-9.28%-13.30%-15.99%-52.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDLXCardlytics3.1115 of 5 stars3.13.00.02.80.02.50.0EBEventbrite4.114 of 5 stars3.12.00.03.83.33.30.6EVEREverQuote4.3575 of 5 stars3.65.00.00.03.44.21.9HCATHealth Catalyst3.9 of 5 stars3.31.00.03.82.02.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDLXCardlytics 2.14Hold$3.5086.17% UpsideEBEventbrite 2.20Hold$4.83111.06% UpsideEVEREverQuote 3.17Buy$32.5034.85% UpsideHCATHealth Catalyst 2.58Moderate Buy$8.00127.27% UpsideCurrent Analyst Ratings BreakdownLatest HCAT, EVER, EB, and CDLX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $4.006/17/2025HCATHealth CatalystBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral5/8/2025CDLXCardlyticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.00 ➝ $2.505/8/2025HCATHealth CatalystCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $9.005/8/2025HCATHealth CatalystStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$5.00 ➝ $5.505/6/2025EVEREverQuoteJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $30.005/6/2025EVEREverQuoteNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$38.00 ➝ $38.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDLXCardlytics$278.30M0.35N/AN/A$1.38 per share1.36EBEventbrite$325.07M0.67$0.03 per share89.76$1.81 per share1.27EVEREverQuote$500.19M1.72$1.04 per share23.16$3.80 per share6.34HCATHealth Catalyst$306.58M0.80$0.34 per share10.35$6.00 per share0.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDLXCardlytics-$189.30M-$3.56N/AN/AN/A-65.41%-172.36%-42.07%8/6/2025 (Confirmed)EBEventbrite-$15.57M-$0.19N/AN/AN/A-5.66%-10.12%-2.16%8/7/2025 (Estimated)EVEREverQuote$32.17M$1.0223.6329.75N/A6.64%35.40%22.81%8/4/2025 (Estimated)HCATHealth Catalyst-$69.50M-$1.15N/AN/AN/A-23.34%-6.14%-2.74%8/7/2025 (Estimated)Latest HCAT, EVER, EB, and CDLX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025EBEventbrite-$0.08N/AN/AN/A$71.67 millionN/A8/7/2025Q2 2025HCATHealth Catalyst$0.05N/AN/AN/A$80.59 millionN/A8/6/2025Q2 2025CDLXCardlytics-$0.16N/AN/AN/A$64.06 millionN/A8/4/2025Q2 2025EVEREverQuote$0.33N/AN/AN/A$157.19 millionN/A5/8/2025Q1 2025EBEventbrite-$0.08-$0.07+$0.01-$0.07$72.88 million$73.83 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDLXCardlyticsN/AN/AN/AN/AN/AEBEventbriteN/AN/AN/AN/AN/AEVEREverQuoteN/AN/AN/AN/AN/AHCATHealth CatalystN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDLXCardlytics2.621.191.19EBEventbrite1.221.451.45EVEREverQuoteN/A2.422.42HCATHealth Catalyst0.401.241.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDLXCardlytics68.10%EBEventbrite91.64%EVEREverQuote91.54%HCATHealth Catalyst85.00%Insider OwnershipCompanyInsider OwnershipCDLXCardlytics4.40%EBEventbrite21.46%EVEREverQuote29.79%HCATHealth Catalyst2.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDLXCardlytics50052.50 million50.19 millionOptionableEBEventbrite88094.63 million74.32 millionOptionableEVEREverQuote61035.72 million25.08 millionOptionableHCATHealth Catalyst1,50069.60 million67.79 millionOptionableHCAT, EB, EVER, and CDLX HeadlinesRecent News About These CompaniesHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by AnalystsAugust 2 at 3:20 AM | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) is favoured by institutional owners who hold 81% of the companyJuly 31 at 3:51 AM | finance.yahoo.comHealth Catalyst (HCAT) to Release Earnings on ThursdayJuly 31 at 2:50 AM | marketbeat.com3 Reasons to Avoid HCAT and 1 Stock to Buy InsteadJuly 29, 2025 | finance.yahoo.comWells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ RatingJuly 27, 2025 | finance.yahoo.comWells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ RatingJuly 26, 2025 | insidermonkey.comPatrick NelliJuly 24, 2025 | benefitnews.comBHealth Catalyst, Inc. (HCAT) Stock Competitors & Similar Stocks ...July 23, 2025 | seekingalpha.comAMH Equity Ltd Takes $1.14 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)July 19, 2025 | marketbeat.com3 Unprofitable Stocks We Approach with CautionJuly 18, 2025 | finance.yahoo.comHealth Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025July 17, 2025 | globenewswire.com6HCAT : Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5...July 9, 2025 | benzinga.comEvercore ISI Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $4.00July 9, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 8, 2025 | marketbeat.comHCAT - Health Catalyst Inc Key Metrics - MorningstarJuly 4, 2025 | morningstar.comMAccelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks MarketplaceJuly 1, 2025 | prnewswire.comHealth Catalyst, Inc. (HCAT) Income Statement - Yahoo FinanceJune 26, 2025 | finance.yahoo.comHealth Catalyst (HCAT) Upgraded to Buy: Here's WhyJune 19, 2025 | zacks.comHealth Catalyst (NASDAQ:HCAT) shareholders have endured a 88% loss from investing in the stock five years agoJune 19, 2025 | finance.yahoo.comData Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The RestJune 17, 2025 | msn.comHCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding UncertaintyJune 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback Stocks3 Stocks to Buy Ahead of the Upcoming Earnings SeasonBy Chris Markoch | July 11, 2025View 3 Stocks to Buy Ahead of the Upcoming Earnings SeasonCongress Is Dumping These 5 Stocks—Should You Follow?By Thomas Hughes | July 25, 2025View Congress Is Dumping These 5 Stocks—Should You Follow?D-Wave Rises 12% in 1 Day, Beating Rivals: What Caused the Spike?By Nathan Reiff | July 22, 2025View D-Wave Rises 12% in 1 Day, Beating Rivals: What Caused the Spike?Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025View Why the American Eagle Stock Rally Isn't Just Speculation HCAT, EB, EVER, and CDLX Company DescriptionsCardlytics NASDAQ:CDLX$1.88 -0.16 (-7.84%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.15 +0.28 (+14.63%) As of 08/1/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Eventbrite NYSE:EB$2.29 -0.15 (-6.15%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$2.30 +0.00 (+0.22%) As of 08/1/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eventbrite, Inc. operates a two-sided marketplace that provides self-service ticketing and marketing tools for event creators in the United States and internationally. Its platform integrates components needed to plan, promote, and produce live events that allow creators to reduce friction and costs, enhance reach, and drive ticket sales. The company was formerly known as Mollyguard Corporation and changed its name to Eventbrite, Inc. in 2009. Eventbrite, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.EverQuote NASDAQ:EVER$24.10 -0.49 (-1.99%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$24.42 +0.32 (+1.34%) As of 08/1/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.Health Catalyst NASDAQ:HCAT$3.52 -0.13 (-3.56%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.54 +0.02 (+0.43%) As of 08/1/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
